Project - Tobacco to cure cancer
Our laureate atb therapeutics, based near Marche-en-Famenne (B), has developed a new class of cancer drugs from tobacco derived plants:... View Article
Our laureate atb therapeutics, based near Marche-en-Famenne (B), has developed a new class of cancer drugs from tobacco derived plants:... View Article
The cells of some cancers have the particularity of making a protein, TSP-1, in very large quantities. These position themselves... View Article
Mablink Bioscience is developing a new generation of anti-cancer “missiles” that are up to 10 x more effective thanks to... View Article
Neuroblastoma is a tumour of the peripheral nervous system with an incidence of 1 per 100,000 children. It carries one... View Article
Precirix (formerly Camel-IDS) is a biotech company located in Jette (B) that was founded in 2014 as part of the... View Article
Biogazelle is a Contract Research Organisation (CRO) renowned for its expertise in sequencing. This satellite of the University of Ghent,... View Article
Hepatocellular carcinoma is one of the deadliest forms of cancer. 600 new cases are diagnosed in Belgium every year. Its... View Article
DNAlytics’ core business is carrying out statistical analyses of client-generated data (from any player in the healthcare sector) in order... View Article
Renal cell carcinoma (RCC) is the most common form of kidney cancer, representing 90% to 95% of all cases. It... View Article